Abstract 5960: Targeting CDK8: A translatable therapeutic approach for fusion-positive aRMS
Susu Zhang(Vanderbilt University), Kimberly Stegmaier(Broad Institute), Clare F. Malone(Arup Group (United States)), Kenneth N. Ross(Broad Institute), Elizabeth Pereira Mendes(Duke University), Giulia DiGiovanni(Dana-Farber Cancer Institute), Christian Cerda-Smith(Duke University), Kris C. Wood(Duke University), Corinne M. Linardic(Duke University), Kathleen Engel(Broad Institute), Alexander L. Kovach(Duke University), Rex C. Bentley(Duke University), Christopher M. Counter(Duke University), Kristianne M. Oristian(Duke University), Leen Barbar(Duke University), Diyana Granum(Duke University), Seth P. Zimmerman(Duke Medical Center), Özgün Erdoğan(Duke University), Marissa Just(Duke University), Assil Fahs(Lebanese University), Brian Guedes(Duke University), Jack F. Shern(National Institutes of Health)
Cited by 0
Related Papers
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
|Science|2006|5.5k
Gene expression correlates of clinical prostate cancer behavior
|Cancer Cell|2002|2.5k
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
|Journal of Clinical Investigation|2014|717
Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
|Cancer Discovery|2016|632
Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study
|Journal of Clinical Oncology|2009|507